Impact of Multi-Cancer Early Detection Test on Late-Stage Cancer Diagnosis
Background NHS-Galleri, a randomized controlled trial, evaluates the clinical utility of a blood-based multi-cancer early detection (MCED) test added to usual care among individuals aged 50-77 years in England. Methods Peripheral blood was collected at up to 3 annual visits. Following baseline blood collection, partici...